ADMA Biologics 15min chart shows Bollinger Bands narrowing, KDJ death cross.

ADMA Biologics's 15-minute chart has exhibited a narrowing of Bollinger Bands, accompanied by a KDJ Death Cross as of September 22, 2025, at 14:45. This suggests a decrease in the magnitude of stock price fluctuations, coupled with a shift in momentum towards the downside, potentially leading to further decreases in stock price.

ADMA Biologics (ADMA) ended the recent trading session at $15.30, reflecting a -5.03% change from the preceding day's closing price. This move lagged behind the S&P 500's daily gain of 0.47%, while the Dow and tech-heavy Nasdaq added 0.11% and 0.94%, respectively Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note^[1].

Over the past month, ADMA Biologics' stock has dropped by 5.18%, underperforming the Medical sector's gain of 5.49% and the S&P 500's gain of 2.32% Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note^[1]. Analysts expect the company to post earnings of $0.16 per share in its upcoming release, representing year-over-year growth of 6.67% Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note^[1]. The consensus estimate for revenue is $130.1 million, up 8.56% from the prior-year quarter.

Technical indicators also suggest a potential downward trend. As of September 22, 2025, at 14:45, ADMA Biologics' 15-minute chart exhibited a narrowing of Bollinger Bands, accompanied by a KDJ Death Cross. This combination indicates a decrease in the magnitude of stock price fluctuations and a shift in momentum towards the downside, potentially leading to further decreases in stock price .

Valuation metrics show that ADMA Biologics is currently being traded at a Forward P/E ratio of 28.26, which is a premium compared to its industry average Forward P/E of 19.79 Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note^[1]. The Medical - Biomedical and Genetics industry, to which ADMA Biologics belongs, has a Zacks Industry Rank of 95, placing it in the top 39% of all 250+ industries Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note^[1].

Investors should keep an eye on ADMA Biologics' financial results and any changes in analyst estimates, as these can provide insights into the company's near-term business trends. The Zacks Rank system, which considers these estimate changes, has assigned ADMA Biologics a Zacks Rank of #3 (Hold) Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note^[1].